← FDA DRUG APPROVALS

FDA ANDA · ANDA085253

MECLIZINE HYDROCHLORIDE

Sponsor: ABC HOLDING

APPLICATION
ANDA085253
TYPE
ANDA
ORIGINAL APPROVAL
1977-02-07
LATEST ACTION
1990-11-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MECLIZINE HYDROCHLORIDEDiscontinued
MECLIZINE HYDROCHLORIDE 12.5MG · TABLET · ORAL

Approval history

1990-11-16Labeling · Supplement 40AP
1988-06-27Manufacturing (CMC) · Supplement 39AP
1984-04-06Manufacturing (CMC) · Supplement 36AP
1983-06-29Manufacturing (CMC) · Supplement 35AP
1983-03-08Manufacturing (CMC) · Supplement 34AP
1977-02-07OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →